Close
Smartlab Europe
Inizio Ignite

News

Clariant has agreed to sell its Masterbatches business for approx. USD 1.6 billion

Clariant, a focused and innovative specialty chemical company, has agreed to sell its entire Masterbatches business to PolyOne. The transaction values the Masterbatches business at USD 1,560 million, representing c. 12.2 times the last twelve months reported EBITDA (ending...

Wasdell Group Wins Contract to Provide Direct-to-Patient Distribution Pharmacy Services

The Wasdell Group (Wasdell), a leading outsourcing partner for the pharmaceutical industry, has secured a new contract to supply medicines and dietary supplements directly to consumers from its Swindon site. The partnership with a major healthcare company will see Wasdell...

Teckro launches new software to streamline clinical trials

The company uses machine-learning technology to transform clinical trial protocols from static documents into actionable data for research staff, monitors and sponsors. Users on the platform receive up-to-date study information and with the new software additions, can now provide feedback...

Advantexe Wins Gold for Best Advance in Leadership Simulation from Brandon Hall Group

Advantexe, a global leader in business simulation centric talent development solutions, announced that they have won a 2019 Gold Medal for Best Advance in Leadership Simulation Technology from the Brandon Hall Group for their “Pharmaceutical Business Simulation.” The simulation is...

Inceptua announced that Paul Wituschek has been appointed President North America

Inceptua announced that Paul Wituschek has been appointed President North America. To further strengthen its position as a leading pharmaceutical company and service partner, Inceptua appoints Paul Wituschek as President North America effective 1 January, 2020. Paul will take on...

Janssen to Acquire Investigational Bermekimab from XBiotech

Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc. Bermekimab is an anti-IL-1alpha monoclonal antibody (mAb) in...

Recipharm invests in its US inhalation development service

Recipharm, the contract development and manufacturing organisation (CDMO), has invested USD 450,000 into its Research Triangle Park (RTP), North Carolina, US facility to install a SprayVIEW® system that will support inhalation and nasal product development. The newly acquired system was...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »